Thyroid medication recall elevated to highest risk level by FDA

Vitruvias Therapeutics Inc. is voluntarily recalling nearly 2,000 bottles of Thyroid Tablets, USP, after the product was found to be superpotent, meaning the tablets contain more active ingredient than labeled — a potentially dangerous condition for patients.
By: news4jax.com







